newest glp-1 medications for type 2 diabetes 2025 is looking to bring more medication. Learn about some upcoming trends for the year. 💻: Search “5 GLP-1 Trends to Expect in 2025" to check GoodRx Health for more In the phase 3 ACHIEVE-1

By enhancing insulin function, reducing inflammation, and stabilizing glucose levels, GLP-1 antagonists may support long-term weight management and lower the risk of metabolic diseases like Type 2 diabetes and heart disease

You may experience fatigue or get sick more often

Caffeine 3-6 Caffeine is an adenosine-receptor antagonist that promotes inotropic effects in the heart and release of catecholamines to facilitate stimulatory effects

In rats, mice, marmosets and human intestinal tissue, GLP-2R localizes to cells residing immediately below the basolateral membrane of enterocytes, which are subepithelial myofibroblasts as marked by SMA (Orskov et al., 2005) (Figure 1 and Table 3)

Nepal, M., Mohamed, M.F., Blade, R., Eldesouky, H.E., N, A.T., Seleem, M.N., et al., ACS Infect